1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 26 JANUARY 2015

Cancer Drug News 26 JANUARY 2015

  • January 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - CAR-T Market Gaining Traction
Industry Brief - EC Favours Iclusig's Approved Indications Throughout Europe
Industry Brief - Hybrigenics Launches Inecalcitol Phase II Study In CML
Industry Brief - Curis/Aurigene Collaborate To Develop Immuno-Oncology/Precision Oncology Targets
Industry Brief - Celator's CPX-351 Gains FDA Fast Track Designation
Industry Brief - BioInvent Reaches Agreement For BI-1206 Phase I/II Trial In CLL/NHL
Industry Brief - Milestone Triggered As Novartis' Jakavi Gains CHMP Positive Opinion For Polycythaemia Vera
Industry Brief - Theravectys Secures Grant From Bpifrance
Industry Brief - Qu Biologics Initiates Phase IIa Trial Of QBKPN SSI In NSCLC
Industry Brief - CHMP Adopts Positive Opinion On Abraxane For First-Line NSCLC
Industry Brief - Verastem's VS-5584 Gains EC Orphan Designation For Mesothelioma
Industry Brief - ESSA Raises Funds To Complete EPI-506 Phase I/II PCA Programme
Industry Brief - Enzalutamide Phase II MCRPCA Trial Meets Primary Endpoint
Industry Brief - Aprea Granted EU Orphan Designation For APR-246 In OC
Industry Brief - Karcinolys' Oncolytic Virus Myb34.5 Gains US/EU Orphan Designations In PC
Industry Trend Analysis - ASCO GI 2014 Indicates Future Market For Hard-To-Treat Upper GI Tract Cancers
Industry Brief - Provectus Granted Chinese Patent Allowance For Rose Bengal Synthesis
Industry Brief - Tiziana Licenses Milciclib From Nerviano
Industry Brief - PCI Biotech's US Amphinex Phase II Programme Receives FDA Approval
Industry Trend Analysis - Undulations In CytRx' Share Price To Continue Until Release Of More Definitive Data
Industry Brief - MedImmune/NCI Enter Partnership To Advance Oncology Research
Industry Brief - Array To Acquire Global Rights To Encorafenib From Novartis
Industry Trend Analysis - Clovis To Transform As Pipeline Matures
Industry Brief - Enrolment Begins In Gem's Phase II Trial Of GPX-150 In Soft Tissue Sarcoma
Industry Brief - CytRx' Aldoxorubicin Phase IIb STS Trial Results Have Room For Improvement
Industry Brief - BMG Grants Distribution Rights To Ferrer For GelX Rinse/Spray

Table Of Contents

Cancer Drug News 26 JANUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Lung Cancer: Analytical Tool

August 2016 $ 8096

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.